Day One Biopharmaceuticals Inc
DAWN - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.22B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $2.22 Billion |
|---|---|
| Enterprise Value | $2.03 Billion |
| Earnings per Share | $-1.04 |
| Beta | -1.75 |
| Outstanding Shares | 103,381,315 |
Return
| Return on Equity | -24.33% |
|---|---|
| Return on Assets | -21.13% |
| Return on Invested Capital | -26.82% |
Valuation & Multiples
| P/E Ratio | -31.2 |
|---|---|
| PEG | 46.14 |
| Price to Sales | 21.53 |
| Price to Book Ratio | 5.38 |
| Enterprise Value to Revenue | 12.85 |
| Enterprise Value to EBIT | -16.94 |
| Enterprise Value to Net Income | -19 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Last Earnings Call
Report Date
May 13, 2026
EPS Estimate
$-0.28
Consensus analyst estimateRevenue Estimate
$55.10 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 1.06, the ratio is above 1, so institutions hold more puts than calls. That is a more cautious stance.
| Put/Call Ratio | 1.0621▲ 18.39% |
|---|---|
| Total Calls | 804,000▲ 24.59% |
| Total Puts | 853,900▲ 50.68% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 84.04%▲ 5.29% |
|---|---|
| Total Invested | $1.85B▲ 143.64% |
| Investors Holding | 221▲ 21.00% |
About Day One Biopharmaceuticals Inc
20 employees
